Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy

Clinical and Experimental Nephrology

Volumn 17, Issue 1, 2013, Pages 73-82

  Wada, Yukihiro ^a   Ogata, Hiroaki ^a   Takeshige, Yui ^a   Takeshima, Akiko ^a   Yoshida, Noriyo ^a   Yamamoto, Masahiro ^a   Ito, Hidetoshi ^a   Kinugasa, Eriko ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

IgA nephropathy; IgA IgG nephropathy; IgG deposition

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMPLETE REMISSION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG PULSE THERAPY; FEMALE; FOLLOW UP; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN DEPOSITION; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; MESANGIUM; PROTEINURIA; REMISSION; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; STEROID THERAPY; TONSILLECTOMY;

ADOLESCENT; ADULT; BIOPSY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; REAGENT STRIPS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; URINALYSIS; URINE; YOUNG ADULT;

EID: 84874116906     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0660-0     Document Type: Article

References (23)

1. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347:738-48.
2. Tomino Y, Sakai H. Special study group (IgA nephropathy) on progressive glomerular disease. Clinical guidelines for immunoglobulin A (IgA) nephropathy in Japan, second version. Clin Exp Nephrol. 2003;7:93-7.
3. Emancipator SN. IgA nephropathy and Henoch-Schönlein syndrome. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall's pathology of the kidney. Philadelphia: Lippincott-Raven Publishers; 1998, p. 479-539.
4. Berger J, Hinglais N. Les depots intercapillaires d'IgA-IgG (intercapillary deposits of IgA-IgG). J Urol Nephrol. 1968;74:694-5.
5. Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest. 1980;66:1432-6.
6. Julian BA, Tomana M, Novak J, Mestecky J. Progress in the pathogenesis of IgA nephropathy. Adv Nephrol. 1999;29:53-72.
7. Novak J, Julian BA, Tomana M, Mestecky J. Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol. 2001;21:310-27.
8. Kanemoto K, Tobita N, Anzai M, Matsumura C, Udagawa J, Kitamura H, et al. Multilateral investigation of IgA-IgG co-deposition in pediatric IgA nephropathy and Henoch-Schonlein purpura nephritis. Jpn J Pediatric Nephrol. 2009;2009(22):26-31.
9. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, et al. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis. 2007; 50:927-37.
10. Matsuo S. Clinical guides for immunoglobulin A (IgA) nephropathy in Japan, third version. Jpn J Nephrol. 2011;53:123-35.
11. Haas M. IgA nephropathy and Henoch-Schönlein purpura nephritis. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, editors. Heptinstall's pathology of the kidney, 6th edn. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 423-86.
12. Okada K, Funai M, Morimoto Y, Kagami S, Yano I, Kawakami K. IgA nephropathy in Japanese children and adults: a comparative study of clinicopathological features. Am J Nephrol. 1990;10:191-7.
13. Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest. 2009;119:1668-77.
14. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest. 1999;104:73-81.
15. Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int. 2005;67:504-13.
16. Kiryluk K, Moldoveanu Z, Sanders JT, Eison TM, Suzuki H, Julian BA, et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int. 2011;80:79-87.
17. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol. 2004; 24:179-96.
18. Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38:736-42.
19. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts ISD, Troyanov S, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76:534-45.
20. Roberts ISD, Cook HT, Troyanov S, Alpers C, Amore A, Barratt J, et al. The Oxford classification of IgA nephropathy: pathology, definition, correlation, and reproducibility. Kidney Int. 2009;76:546-56.
21. Nieuwhof C, Kruytzer M, Frederiks P. Van Breda Vriesman PJ. Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy. Am J Kidney Dis. 1998;31:962-70.
22. Van Dixhoorn MG, Sato T, Muizert Y, van Gijlswijk-Janssen DJ, De Heer E, Daha MR. Combined glomerular deposition of polymeric rat IgA and IgG aggravates renal inflammation. Kidney Int. 2000;58:90-9.
23. Bellur S, Troyanov S, Cook HT. Roberts ISD on behalf of a working group of the international IgA nephropathy network and the renal pathology society. Nephrol Dial Transpl. 2011;26:2533-6.